SCHEMBL18973009

SCHEMBL18973009

CCC(=O)NCCOCCCCCCOCCNC(C)C

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
RECQL P46063 1/20 0.39
KDM4E B2RXH2 4/20 0.38
EPHX2 P34913 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
POLB P06746 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
TLR2 O60603 1/20 0.36
MAPT P10636 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ACHE P22303 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18738984 0.93 MEN1 (0.47) MEN1KMT2ARECQLKDM4ECYP1A2
SCHEMBL25851515 0.92 MEN1 (0.47) MEN1KMT2ARECQLKDM4ECYP1A2
SCHEMBL25885013 0.92 MEN1 (0.52) MEN1KMT2ARECQLKDM4ECYP1A2
SCHEMBL24379925 0.92 MEN1 (0.50) MEN1KMT2ARECQLKDM4ECYP1A2
SCHEMBL23806133 0.92 MEN1 (0.50) MEN1KMT2ARECQLKDM4ECYP1A2
SCHEMBL22014884 0.92 MEN1 (0.50) MEN1KMT2ARECQLKDM4ECYP1A2
SCHEMBL25466890 0.92 MEN1 (0.50) MEN1KMT2ARECQLKDM4ECYP1A2
SCHEMBL18908647 0.92 MEN1 (0.50) MEN1KMT2ARECQLKDM4ECYP1A2
SCHEMBL25600684 0.83 KMT2A (0.53) MEN1KMT2ARECQLEPHX2CYP2D6
SCHEMBL25729590 0.81 KMT2A (0.43) MEN1KMT2ARECQLEPHX2TLR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9994855-B2 Compositions and methods for modulating growth hormone receptor expression IONIS PHARMACEUTICALS, INC. (US) 2018-06-12 US disclosed
US-20170166899-A1 COMPOSITIONS AND METHODS FOR MODULATING GROWTH HORMONE RECEPTOR EXPRESSION IONIS PHARMACEUTICALS, INC. (US) 2017-06-15 US disclosed